Intensive Care News and Research

RSS

Better physical functioning associated with remission of general anxiety, PTSD symptoms

In a two-year longitudinal study involving 13 intensive care units in four U.S. hospitals, researchers found that better physical functioning — basic and complex activities considered essential for maintaining independence — is associated with remission of general anxiety and post-traumatic stress disorder (PTSD) symptoms. These findings may help clinicians be better prepared for caring for the growing number of survivors of critical illness, potentially leading to a better quality of recovery for patients.

8 Jan 2015

Loyola to be included in "Guinness World Records" 2015 edition for neonatal care

Loyola University Medical Center will be included in the "Guinness World Records" 2015 edition for caring for the world's smallest baby.

2 Jan 2015

FDA receives IDE application for CytoSorbents' CytoSorb cardiac surgery trial

CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced today that it has submitted an Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to conduct its proposed clinical trial using CytoSorb® intra-operatively in patients undergoing complex cardiac surgery requiring the use of a heart-lung machine.

31 Dec 2014

Former baseball player describes his journey in diabetes management

Former professional player Dmitri Young impressed the baseball world when he appeared at a game this summer, having lost about 100 pounds since he last played in 2010.

31 Dec 2014

Novel device may speed up medical decision-making for critically injured trauma patients

A tool that surgeons use for monitoring a patient's blood level in physicians' offices may also save valuable minutes in medical decision-making for critically injured trauma patients, according to study results published in the January 2015 issue of the Journal of the American College of Surgeons.

30 Dec 2014

Deeper cooling does not reduce NICU death among newborns with hypoxic ischemic encephalopathy

Among full-term newborns with moderate or severe hypoxic ischemic encephalopathy (damage to cells in the central nervous system from inadequate oxygen), receiving deeper or longer duration cooling did not reduce risk of neonatal intensive care unit death, compared to usual care, according to a study in the December 24/31 issue of JAMA.

24 Dec 2014

Comprehensive care improves health of high-risk, chronically ill children, reduces hospital costs

High-risk children with chronic illness who received care at a clinic that provided both primary and specialty care and features to promote prompt effective care had an increase in access to care and parent satisfaction and a reduction in serious illnesses and costs, according to a study in the December 24/31 issue of JAMA.

24 Dec 2014

CorMedix signs Neutrolin sales/distribution agreement with Arabian Trade House

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, announced today the first signed Middle East sales/distribution agreement for lead product Neutrolin with distributor Arabian Trade House in the Kingdom of Saudi Arabia.

23 Dec 2014

CytoSorbents starts trading on The Nasdaq Capital Market

CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced that it will commence trading today on The Nasdaq Capital Market under its current ticker symbol "CTSO".

23 Dec 2014

Physicians, social worker, dietitian constitute core hospital care team

Doctors and nurses are traditionally thought to be the primary caretakers of patients in a typical hospital setting.

22 Dec 2014

Experimental drug warrants clinical study for treatment of Ebola infection

A case report, published in The Lancet today, describes the successful treatment of Ebola using a new drug under clinical development for vascular leakage (FX06, a fibrin-derived peptide).

19 Dec 2014

SPECT scan measures brain activity during seizures

Loyola University Medical Center is offering epileptic patients an imaging scan that records brain activity during seizures.

18 Dec 2014

Ortho-Clinical Diagnostics announces availability of NEPHROCHECK Test System for AKI patients

Ortho-Clinical Diagnostics, Inc. today announced the nationwide availability to hospitals of the NEPHROCHECK Test System designed to help healthcare providers identify patients at risk of developing moderate or severe acute kidney injury (AKI) within 12 hours of patient assessment.

From Ortho-Clinical Diagnostics, Inc. 16 Dec 2014

Two-drug combination before surgery benefits women with triple-negative breast cancer

A breast cancer specialist and clinical researcher at Women & Infants Hospital of Rhode Island presented research yesterday at the 2014 San Antonio Breast Cancer Symposium showing that adding either the chemotherapy drug carboplatin or the blood vessel-targeting drug bevacizumab to the standard treatment of chemotherapy before surgery helped women who have the basal-like subtype of triple-negative breast cancer.

15 Dec 2014

Key steps to improve care for pregnant mothers and babies affected by CDH

A new study has revealed key steps for hospitals to improve care for pregnant mums and babies affected by a life-threatening condition.

12 Dec 2014

Multiple factors influence survival of extremely premature infants

Multiple factors influence how well a severely premature infant (23 weeks gestation) will do after birth and over the long-term, according to researchers at Loyola University Chicago Stritch School of Medicine. These findings were published in the latest issue of the American Journal of Perinatology.

10 Dec 2014

FDA Advisory Committee votes in favor of Actavis' ceftazidime-avibactam

Actavis plc today announced that the Anti-Infective Drugs Advisory Committee convened by the U.S. Food and Drug Administration has voted to recommend approval of Actavis' New Drug Application (NDA) for ceftazidime-avibactam, an investigational antibiotic being developed to treat hospitalized patients when limited or no treatment options are available for complicated intra-abdominal infections (cIAI) (in combination with metronidazole) and complicated urinary tract infections (cUTI) (including acute pyelonephritis) caused by Gram-negative pathogens.

5 Dec 2014

Simple treatments for Ebola patients not given sufficient priority

The widespread misconception that there are no proven treatments for Ebola virus disease has meant that simple treatments – especially intravenous fluids and electrolytes, which could reduce the number of deaths caused by the virus – have been neglected, according to a new Comment, published in The Lancet.

5 Dec 2014

Study on hospital alarm fatigue records more than 2.5 million alarms in one month

Jessica Zègre-Hemsey, a cardiac monitoring expert at the University of North Carolina at Chapel Hill, and her colleagues at the University of California San Francisco, revealed more than 2.5 million alarms were triggered on bedside monitors in a single month - the first figure ever reported from a real-world hospital setting.

5 Dec 2014

Elegant Medical to receive patent for groundbreaking Stethos electronic stethoscope

Elegant Medical LLC today announced it will receive an issued patent from the US Patent and Trademark Office for its groundbreaking Stethos electronic stethoscope, the most significant advancement to the stethoscope in half a century.

3 Dec 2014

Intensive Care News and Research

Better physical functioning associated with remission of general anxiety, PTSD symptoms

Loyola to be included in "Guinness World Records" 2015 edition for neonatal care

FDA receives IDE application for CytoSorbents' CytoSorb cardiac surgery trial

Former baseball player describes his journey in diabetes management

Novel device may speed up medical decision-making for critically injured trauma patients

Deeper cooling does not reduce NICU death among newborns with hypoxic ischemic encephalopathy

Comprehensive care improves health of high-risk, chronically ill children, reduces hospital costs

CorMedix signs Neutrolin sales/distribution agreement with Arabian Trade House

CytoSorbents starts trading on The Nasdaq Capital Market

Physicians, social worker, dietitian constitute core hospital care team

Experimental drug warrants clinical study for treatment of Ebola infection

SPECT scan measures brain activity during seizures

Ortho-Clinical Diagnostics announces availability of NEPHROCHECK Test System for AKI patients

Two-drug combination before surgery benefits women with triple-negative breast cancer

Key steps to improve care for pregnant mothers and babies affected by CDH

Multiple factors influence survival of extremely premature infants

FDA Advisory Committee votes in favor of Actavis' ceftazidime-avibactam

Simple treatments for Ebola patients not given sufficient priority

Study on hospital alarm fatigue records more than 2.5 million alarms in one month

Elegant Medical to receive patent for groundbreaking Stethos electronic stethoscope

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News